Serum interleukin-۱۸ and extent of coronary artery disease in unstable angina

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 172

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RYA-14-3_003

تاریخ نمایه سازی: 2 شهریور 1401

Abstract:

BACKGROUND: Interleukin-۱۸ (IL-۱۸) is an inflammatory marker with challenging role in atherosclerosis. The present study was carried out aiming to evaluate the association between IL-۱۸ serum level and extent and severity of atherosclerosis among young patients with unstable angina (UA) who underwent coronary angiography.METHODS: This cross sectional study was performed from July to October ۲۰۱۵ in Chamran heart center, Isfahan, Iran. ۱۸۰ patients with UA in the age range of below ۵۰ years entered the study. All demographic, past history, physical examination, electrocardiogram (EKG or ECG), and transthoracic echocardiogram (TTE) data were collected. Serum level of IL-۱۸ was measured using enzyme-linked immunosorbent assay (ELISA) method. A coronary angiography was performed on all patients to evaluate the presence and the incidence rate of coronary artery disease (CAD).RESULTS: Mean age of the patients was ۴۶.۰ ± ۴.۶ years [۴۷.۴ ± ۴.۳ and ۴۵.۹ ± ۴.۹ among patients with CAD and normal coronary, respectively (P = ۰.۰۴۰)]. Rate of severe CAD was greater among men compared to women with values ۶۷.۸% and ۵۱.۸%, respectively (P = ۰.۰۳۲). The median [interquartile range (IQR)] value of serum IL-۱۸ among patients with CAD [۱۹۲.۸۶ (۱۲۸.۰۳,۳۲۵.۷۵)] was higher than normal coronary subjects [۱۷۲.۸۱ (۱۳۹.۷۷,۲۴۳.۲۱)], however it was not significant (۱۹۸.۴ ± ۹۳.۵, P = ۰.۲۸۷). A significant difference between serum IL-۱۸ level and number of stenosis vessels was detected only among women (P = ۰.۰۳۲).CONCLUSION: Serum IL-۱۸ level can predict the number of coronary arteries with significant stenosis among women with unstable angina. 

Authors

Masoumeh Sadeghi

Professor, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Maryam Gheraati

Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Azam Soleimani

Assistant Professor, Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Afshin Amirpour

Assistant Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Marzieh Taheri

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Safoura Yazdekhasti

Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Elham Valikhani

Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, ...
  • Libby P. The pathogenesis of atherosclerosis . In: Kasper DL, ...
  • Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, ...
  • Manton KG. The global impact of noncommunicable diseases: Estimates and ...
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation ...
  • Nicholls ES, Peruga A, Restrepo HE. Cardiovascular disease mortality in ...
  • Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, ...
  • Roohafza H, Sadeghi M, Sarrafzadegan N, Baghaei A, Kelishadi R, ...
  • Khayyam-Nekouei Z, Neshatdoost H, Yousefy A, Sadeghi M, Manshaee G. ...
  • Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, ...
  • Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson ...
  • Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, ...
  • Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, ...
  • Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, ...
  • Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, ...
  • Roohafza H, Sadeghi M, Shahnam M, Bahonar A, Sarafzadegan N. ...
  • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, ...
  • Mazaheri S, Sadeghi M, Sarrafzadegan N, Sanei H, Hekmatnia A, ...
  • Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, ...
  • Chen MC, Chen CJ, Yang CH, Wu CJ, Fang CY, ...
  • Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, ...
  • Corson MA. Emerging inflammatory markers for assessing coronary heart disease ...
  • Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, ...
  • Mallat Z, Henry P, Fressonnet R, Alouani S,Scoazec A, Beaufils ...
  • Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J ...
  • نمایش کامل مراجع